The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Anido Vicente Jr since 2005.
The trader's CIK number is 1207633.
At the time of the last reporting, Anido Vicente Jr was the President & CEO of Aerie Pharmaceuticals Inc. (stock ticker symbol AERI).
Also see all insider trading activities at Aerie Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | ISTA | 0 | $0 | 0 | $0 | 298,120 | $688,596 |
| 2009 | ISTA | 81,819 | $160,083 | 0 | $0 | 0 | $0 |
| 2008 | ISTA | 188,362 | $154,416 | 0 | $0 | 0 | $0 |
| 2005 | ISTA | 13,300 | $101,444 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | AERI | 26,250 | $510,300 | 0 | $0 | 0 | $0 |
| 2018 | AERI | 0 | $0 | 200,000 | $12,477,400 | 200,000 | $598,750 |
| 2013 | AERI | 28,000 | $280,000 | 0 | $0 | 0 | $0 |
1. Ista Pharmaceuticals Inc (ISTA)
2. Aerie Pharmaceuticals Inc (AERI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-06-06 | ISTA | Option Ex | 200,000 | 1.25 | 250,000 |
| 2012-05-08 | ISTA | Option Ex | 98,120 | 4.47 | 438,596 |
| 2009-02-25 | ISTA | Buy | 3,444 | 1.97 | 6,784 |
| 2009-02-26 | ISTA | Buy | 27,500 | 1.98 | 54,450 |
| 2009-02-24 | ISTA | Buy | 38,579 | 1.93 | 74,380 |
| 2009-02-25 | ISTA | Buy | 12,296 | 1.99 | 24,469 |
| 2008-12-11 | ISTA | Buy | 83,000 | .99 | 82,253 |
| 2008-12-11 | ISTA | Buy | 7,550 | .84 | 6,349 |
| 2008-12-09 | ISTA | Buy | 89,812 | .67 | 59,814 |
| 2008-12-10 | ISTA | Buy | 8,000 | .75 | 6,000 |
| 2005-05-12 | ISTA | Buy | 1,800 | 7.58 | 13,653 |
| 2005-05-12 | ISTA | Buy | 11,500 | 7.63 | 87,791 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-09-09 | AERI | Buy | 26,250 | 19.44 | 510,300 |
| 2018-06-11 | AERI | Option Ex | 50,000 | 3.15 | 157,500 |
| 2018-06-11 | AERI | Sale | 50,000 | 62.41 | 3,120,600 |
| 2018-06-08 | AERI | Sale | 50,000 | 63.94 | 3,196,750 |
| 2018-06-07 | AERI | Sale | 50,000 | 62.43 | 3,121,500 |
| 2018-06-08 | AERI | Option Ex | 50,000 | 3.02 | 151,250 |
| 2018-06-06 | AERI | Sale | 50,000 | 60.77 | 3,038,550 |
| 2018-06-07 | AERI | Option Ex | 50,000 | 2.90 | 145,000 |
| 2018-06-06 | AERI | Option Ex | 50,000 | 2.90 | 145,000 |
| 2013-10-30 | AERI | Buy | 28,000 | 10.00 | 280,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Anido Vicente Jr (President & CEO of Aerie Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.